FDA Grants TA Status for ANDA213093 from QILU PHARM CO LTD
The FDA has granted TA (Tentative Approval) status for ANDA213093 submitted by QILU PHARM CO LTD.
Asset / Drug
Drug and asset intelligence for ANDA213093 with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.